Spectrum Dynamics Medical Receives FDA 510(k) Clearance for Veritas.AI™, Its AI-Powered Noise Reduction Platform for VERITON-CT
29.01.2026 - 14:05:22| Spectrum Dynamics Medical, Inc. / Key word(s): Miscellaneous 29.01.2026 / 14:05 CET/CEST The issuer is solely responsible for the content of this announcement. SARASOTA, Fla., Jan. 29, 2026 /PRNewswire/ -- Spectrum Dynamics Medical, a global leader in digital nuclear medicine imaging solutions, today announced that it has received FDA 510(k) clearance for Veritas.AI™ Noise Reduction, its advanced artificial intelligence platform designed to significantly enhance image quality, diagnostic confidence, and operational efficiency on the VERITON-CT® digital SPECT/CT system. ![]() Thera-IQ.AI, purpose-built for Lu-177 theranostics, improving post-treatment image quantitative accuracy, and harmonizing noise across time points, which may enhance the accuracy of dosimetry and improve lesion detectability. MIBG-IQ.AI, designed for I-123 MIBG imaging, enabling up to 50% reduction in scan time, delivering safer, faster, and more comfortable exams for children.When combined with the VERITON-CT's 360° CZT digital detector architecture, wide-bore design, and quantitation-ready workflows, Veritas.AI further strengthens Spectrum Dynamics' leadership in digital SPECT/CT imaging—supporting routine clinical practice, advanced theranostics, and clinical research."Receiving FDA clearance for Veritas.AI is a significant milestone for Spectrum Dynamics and for the nuclear medicine community," said Tomer Gabay, Chief Executive Officer of Spectrum Dynamics Medical. "As innovation leaders, we are incredibly excited to bring this powerful AI innovation solution to our customers. Veritas.AI strengthens our commitment to precision imaging by delivering clearer images, greater clinical confidence, and more efficient workflows, while helping hospitals prepare for the rapid growth of theranostics and quantitative SPECT/CT."This FDA clearance underscores Spectrum Dynamics' continued investment in AI-driven innovation, setting a new standard for clarity, confidence, and clinical value in nuclear medicine.About Spectrum Dynamics MedicalSpectrum Dynamics is spearheading the transformation of SPECT imaging systems from analog to digital detection technology, enabling hospitals and clinicians to provide healthcare services with improved image quality, efficiency and access to advanced clinical applications. Spectrum Dynamics launched the world first digital cardiac SPECT system, the D-SPECT CARDIO – in 2007. Since then, the D-SPECT has become the system of choice for functional cardiac imaging with hundreds of systems sold worldwide. In 2018, Spectrum Dynamics launched its multipurpose SPECT and SPECT-CT systems – the VERITON® and the VERITON-CT® SPECT/CT, first ring-shaped gantry 360 CZT digital SPECT/CT scanner.For more information, visit www.spectrum-dynamics.comLogo - https://mma.prnewswire.com/media/2365147/Spectrum_Dynamics_Medical___Logo.jpg ![]() 29.01.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. View original content: EQS News |



